2. Kareem RHR, Omer GL, De Donato G, Di Girolamo S, Ali SS, Abdullah AS, et al. Effect of intratympanic steroid injection on hearing loss and tinnitus in sudden sensorineural hearing loss. Aust J Otolaryngol 2025;8:47
4. Michel O. [The revised version of the German guidelines “sudden idiopathic sensorineural hearing loss�]. Laryngorhinootologie 2011;90:290–3. German.
5. Chingath AL, Spoorthi GN, Kalaiah MK, Kumar K, Shastri U. Self-reported communication strategies used by individuals with hearing loss and its influence on the hearing loss related quality of life of their communication partners. Ageing Int 2026;51:8
8. Tejaswini JS, Walia M, Bansal S, Soni S. Efficacy of oral versus intratympanic steroids in the treatment of idiopathic sudden sensorineural hearing loss: a 1-year randomized control trial. Indian J Otol 2023;29:105–10.
9. Ahn JH. Dexamethasone palmitate: a promising intratympanic treatment option for severe sudden hearing loss. Am J Otolaryngol 2026;47:104766
10. Shirwany NA, Seidman MD, Tang W. Effect of transtympanic injection of steroids on cochlear blood flow, auditory sensitivity, and histology in the guinea pig. Am J Otol 1998;19:230–5.
11. Tsuzuki N, Wasano K. Idiopathic sudden sensorineural hearing loss: a review focused on the contribution of vascular pathologies. Auris Nasus Larynx 2024;51:747–54.
12. Tatsuno I, Sugiyama T. Glucocorticoid-induced diabetes mellitus is a risk for vertebral fracture during glucocorticoid treatment. Diabetes Res Clin Pract 2011;93:e18–20.
16. Sadr-Azodi O, Mattsson F, Bexlius TS, Lindblad M, Lagergren J, Ljung R. Association of oral glucocorticoid use with an increased risk of acute pancreatitis: a population-based nested case-control study. JAMA Intern Med 2013;173:444–9.
17. Chang WT, Zee B, Lee HSH, Tong MCF. Dexamethasone eardrop with grommet placement vs intratympanic steroid injection for sudden sensorineural hearing loss: a randomized prospective clinical trial. Am J Otolaryngol 2020;41:102515
18. Chrysouli K, Kollia P, Papanikolaou V, Chrysovergis A. The effectiveness of intratympanic steroid injection in addition to systemic corticosteroids in the treatment of idiopathic sudden sensorineural hearing loss. Am J Otolaryngol 2023;44:103872
19. Han JS, Kim YL, Yu HJ, Park JM, Kim YJ, Choung YH, et al. Safety and efficacy of intratympanic histamine injection as an adjuvant to dexamethasone in a noise-induced murine model. Eur J Pharm Sci 2022;178:106291
21. Sturm JJ, Maurrasse SE, Golub JS. Intratympanic steroid injection. Oper Tech Otolaryngol Head Neck Surg 2021;32:92–8.
25. Komatsubara Y, Tachibana T, Kataoka Y, Kariya A, Furukawa C, Sato A, et al. Application of intratympanic steroid injection as salvage therapy for idiopathic sudden sensorineural hearing loss. Auris Nasus Larynx 2025;52:248–52.
26. Wang SY, Fu WT, Yu M, Sun A, Sun J, Li G. Efficacy analysis of intratympanic injection of dexamethasone at different concentrations for the treatment of unilateral idiopathic sudden sensorineural hearing loss. Am J Otolaryngol 2025;46:104603
27. Canakci H, Arslan E, Tulaci KG, Yazici H. Intratympanic steroid via saturated gelfoam vs. intratympanic injection for sudden sensorineural hearing loss. Auris Nasus Larynx 2025;52:314–8.
28. Aliyeva A, Edizer DT. Efficacy of intratympanic steroid therapy for severe and profound sudden sensorineural hearing loss. Am J Otolaryngol 2024;45:104170
29. Amizadeh M, Fazlinezhad F, Ranjbar M, Hasanalifard M. The efficacy of methylprednisolone acetate nanogel in treating patients with sudden sensorineural hearing loss. Sci Rep 2025;15:12342
31. Lv L, Gao Z, Liu J, Zhuang Y, Hou J, Zhu W, et al. Comparison between postauricular steroid injection and intratympanic steroid perfusion for refractory severe and profound sudden sensorineural hearing loss. Am J Otolaryngol 2022;43:103189
32. Adhikari S, Bhandari C, Sharma B, Rijal N, Upadhyay HP, Shrestha N. Effectiveness of intratympanic steroid injection in treatment of idiopathic sudden sensorineural hearing loss. J Bharatpur Hosp 2025;1:208–11.
33. Chen SL, Ho CY, Chin SC, Chan KC, Wang YC. Intratympanic steroid injection for treating sudden sensorineural hearing loss in patients with hepatitis B virus infection. Am J Otolaryngol 2025;46:104660
34. Chen SL, Ho CY, Chin SC, Chan KC, Wang YC. Sudden sensorineural hearing loss in diabetes mellitus patients receiving intra-tympanic steroid injections. Am J Otolaryngol 2025;46:104576
37. Clark JG. Uses and abuses of hearing loss classification. ASHA 1981;23:493–500.
40. Sakata E, Kitago Y, Murata Y, Teramoto K. [Treatment of Ménière’s disease. Middle ear infusion with lidocaine and steroid solution]. Auris Nasus Larynx 1986;13:79–89. German.
43. Wang Y, Zhao J, Wu J, Ren T, Wu Y. Comparison of side effects of different steroids used in intratympanic injections. Am J Otolaryngol 2024;45:104258
44. Okada M, Hato N, Nishio SY, Kitoh R, Ogawa K, Kanzaki S, et al. The effect of initial treatment on hearing prognosis in idiopathic sudden sensorineural hearing loss: a nationwide survey in Japan. Acta Otolaryngol 2017;137(sup565):S30–3.
45. Amarillo E, Hernández-GarcÃa E, Herrera M, GarcÃa Berrocal JR, GarcÃa Arumà A, Durio E, et al. Sudden hearing loss: national survey in Spain. Acta Otorrinolaringol Esp 2016;67:59–65.
46. Vukelic J, Marzic D, Liovic A, Manestar D, Anic DM. The effect of aging on hearing outcomes after sudden sensorineural hearing loss (SSNHL): a retrospective study. Arch Gerontol Geriatr 2025;137:105932
47. Alexander TH, Harris JP, Nguyen QT, Vorasubin N. Dose effect of intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss: 24 mg/mL is superior to 10 mg/mL. Otol Neurotol 2015;36:1321–7.